NCT03002064 Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients Status UNKNOWN Phase PHASE3
NCT02999087 Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02998528 A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT02998385 Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02997332 Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase PHASE1
NCT02996214 Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU) Status UNKNOWN Phase PHASE4
NCT02994251 A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT02994069 Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02992340 Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC Status TERMINATED Phase PHASE1/PHASE2
NCT02990468 A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02989584 A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02987998 Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC Status TERMINATED Phase PHASE1
NCT02985658 Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer Status NO_LONGER_AVAILABLE Phase N/A
NCT02985255 Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue Status UNKNOWN Phase PHASE2
NCT02983097 Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP Status TERMINATED Phase PHASE1/PHASE2
NCT02980991 Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002) Status COMPLETED Phase PHASE2
NCT02972216 Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy Status COMPLETED Phase N/A
NCT02964689 Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. Status COMPLETED Phase PHASE1
NCT02964013 Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) Status COMPLETED Phase PHASE1
NCT02957266 Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy Status UNKNOWN Phase PHASE3